Omnius schreef op 21 december 2015 16:51:
www.bidnessetc.com/59672-are-gilead-s...Are Gilead Sciences, AstraZeneca Deals a Threat to AbbVie?
Gilead and AstraZeneca signed separate licensing deals this week. Here's how they can impact AbbVie's development pipeline
Dec 19, 2015 at 7:55 am Est
Are Gilead Sciences, AstraZeneca Deals a Threat to AbbVie?Are Gilead Sciences, AstraZeneca Deals a Threat to AbbVie?
By Hannah Ishmael on Dec 19, 2015 at 7:55 am Est
Gilead Sciences, Inc. (NASDAQ:GILD) struck a deal worth up to $2.1 billion with Galapagos NV (ADR) (NASDAQ:GLPG) on Thursday, gaining access to its mid-stage anti-inflammatory drug, filgotinib. The same day, AstraZeneca plc (ADR) (NYSE:AZN) agreed to acquire a majority stake in a small, cancer drugmaker Acerta Pharma for $4 billion.